Adverum Biotechnologies
ADVM
ADVM
101 hedge funds and large institutions have $269M invested in Adverum Biotechnologies in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 16
0.38% less ownership
Funds ownership: 5.89% → 5.51% (-0.38%)
Holders
101
Holding in Top 10
1
Calls
$2.68M
Puts
$237K
Top Buyers
| 1 | +$9.07M | |
| 2 | +$6.96M | |
| 3 | +$2.32M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$2.29M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
+$2.09M |
Top Sellers
| 1 | -$9.15M | |
| 2 | -$7.46M | |
| 3 | -$6.05M | |
| 4 |
Alkeon Capital Management
New York
|
-$4.55M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.04M |